Skip to main content
Erschienen in:

Open Access 01.12.2025 | Research

Nursing contribution to end-of-life care decision-making in patients with neurological diseases on an acute hospital ward: documentation of signs and symptoms

verfasst von: Gudrun Jonsdottir, Runar Vilhjalmsson, Valgerdur Sigurdardottir, Haukur Hjaltason, Marianne Elisabeth Klinke, Helga Jonsdottir

Erschienen in: BMC Nursing | Ausgabe 1/2025

Abstract

Background

Recognizing impending death in patients with neurological diseases presents challenges for nurses and other healthcare professionals. This study aimed to identify nursing contribution to end-of-life (EOL) care decision-making for patients with neurological diseases in an acute hospital ward and to compare signs and symptoms among subgroups of patients.

Methods

In this retrospective study, we analyzed data from 209 patient health records using the Neurological End-Of-Life Care Assessment Tool to evaluate the care in the last 3 to 7 days of life. Key aspects included the need for EOL care, EOL care decision-making, signs and symptoms of imminent death, and communication with relatives. The patient records pertain to patients who died in an acute neurological ward between January 2011 and August 2020; 123 with ischemic stroke, 48 with hemorrhagic stroke, 27 with amyotrophic lateral sclerosis [ALS], and 11 with Parkinson’s disease or extrapyramidal and movement disorders [PDoed]. Both descriptive and inferential statistical analyses were performed to analyze the data.

Results

Nurses identified the need for EOL care in 36% of cases and contributed to EOL decision-making as information brokers (15%), advocates (6%), and supporters (6%). They identified disease progression in 44% of the cases. The mean number of signs and symptoms in both the acute and progressive disease groups was 6.5 and ranged from 1 to 14. Patients with stroke without a documented EOL decision had more severe symptoms, including respiratory congestion (68%) and dyspnea (37%), than those with EOL decision. A higher frequency of no food intake was documented in patients with stroke receiving EOL care (p = 0.007) compared to those without. Among patients with ALS or PDoed, those with EOL decision showed a trend toward a higher frequency of unconsciousness or limited consciousness than those without EOL decision (p = 0.067). For all groups of patients, conversations with relatives occurred in 85% instances and family meetings in 93%.

Conclusions

Nurses made substantial contributions to EOL care decision-making for patients with neurological diseases. To improve early identification of imminent death in patients with neurological diseases in acute hospital wards, healthcare professionals must investigate barriers contributing to delayed recognition.

Clinical trial number

Not applicable
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Recognizing imminent death in patients is challenging for nurses and other healthcare professionals [1, 2]. This may occur across different patient groups, including those with neurological diseases [3, 4, 5, 6, 7, 8]. To comprehend approaching death, clinicians rely on intuition and comprehensive information, including physical and psychological symptoms, tests, conversations with relatives, and observations, to comprehend approaching death [1]. This process is further complicated by organizational factors such as work pace and cultural attitudes towards death [1, 2]. Patients with neurological diseases exhibit numerous and severe signs and symptoms near the end of life (EOL) [4, 9, 10, 11, 12, 13, 14]. Some of these signs and symptoms, such as decreased consciousness, which may resemble typical reversible neurological symptoms such as those of acute stroke, may be temporary [3, 4, 8, 10, 15, 16]. This overlap accentuates the challenge of recognizing imminent death and increases the uncertainty of EOL decision-making in patients with neurological diseases [1].
EOL care marks the final step of palliative care and refers to care provided in the final stage of life, where the focus is shifted from life-sustaining treatment to comfort measures based on individual patient’s needs. This decision is the physician’s responsibility and is formally documented in the patients’ health records (PHRs) Consequently, a change in both medical and nursing treatment should be expected, such as exclusion of resuscitation and intensive care. Despite the different meanings of the terms palliative and EOL care, they are often used interchangeably. EOL care requires complex decision-making, considering the patient’s overall decline across physical, social, spiritual, and psychological dimensions [17, 18, 19]. Nurses are expected to identify signs and symptoms of imminent death, provide timely clinical assessment, and relay information to physicians and other professionals, actively contributing to EOL care decision-making [17, 18, 19]. Nurses must be supportive, advocate for patients, and influence EOL care decision-making [17] while ensuring that the care aligns with the values and preferences of patients and their relatives. In addition to providing holistic and continuous care, nurses must share vital information about signs and symptoms, medication administration, and possible outcomes with both patients who are dying and their relatives [17, 20, 21, 22, 23].
Failure to recognize imminent death may prolong suffering and hinder peaceful death [1, 2, 6, 24, 25, 26]. The clinical guidelines of the Registered Nurses Association of Ontario (RNAO) and existing literature highlight several signs that may indicate disease progression or impending death during the terminal phase of patients with neurological diseases. Some of these signs are progressive weakness; bedbound state; sleepiness; decreased intake of food and fluid; darkened and/or decreased urine output; dysphagia; delirium; decreased level of consciousness; noisy respiration/excessive respiratory tract secretion; dyspnea; change in breathing pattern (Cheyne–Stokes respiration and periods of apnea); and mottling and cooling extremities [16, 17, 27, 28]. Respiratory signs and symptoms including respiratory congestion, Cheyne–Stokes breathing, and dyspnea can induce distress and anxiety for patients, their bedside relatives, and healthcare professionals [29, 30, 31, 32]. Therefore, recognizing and addressing the signs and symptoms of imminent death in the terminal phase of life is important, not only to enhance patient comfort and ensure quality of care but also to support the well-being of relatives and curb stress in healthcare professionals [33].
Patients with neurological diseases often receive brief EOL care, even after extended hospital stays [15, 34, 35, 36, 37, 38]. Our previous study on EOL decision-making revealed that EOL decisions were made more quickly after admission to the hospital in patients with acute neurological conditions such as hemorrhagic and ischemic strokes (median: 4 days) than in those with progressive diseases like amyotrophic lateral sclerosis (ALS) and Parkinson’s disease or extrapyramidal and movement disorders (PDoed) (median: 9 and 22 days, respectively). The findings furthermore suggested that EOL care decisions were influenced by age and stroke diagnosis and not by treatment directives or demographic factors [24]. Several triggers of imminent death may occur in patients with neurological diseases several months prior to their death. These include physical deterioration, dysphagia, severe complex symptoms and pain, weight loss, respiratory issues, recurrent infections, and cognitive decline [39, 40, 41, 42, 43, 44, 45]. Understanding these signs and symptoms requires deep knowledge of the progression and symptom patterns specific to neurological diseases [43, 44, 45, 46, 47]. When using triggers to identify approaching death, careful attention must be given to the trajectory of the disease, which varies between patients and conditions [1, 9, 47, 48, 49, 50, 51]. For instance, being immobile, dependent, or bedbound are often considered general indicators of imminent death [52], but in patients with ALS, these may not signal death because reduced functional capacity can exist for long periods while patients may maintain independence in talking and eating until just hours before death [48, 52]. Conversely, patients with stroke can be paralyzed and immobile after the stroke but may enjoy fruitful and meaningful lives without actively dying [53]. Consciousness level and communication capacity are frequently assessed to monitor neurological disease progression. Changes in these signs may indicate the need to transit patients to EOL care [5, 16, 54]. However, these signs are not always reliable predictors of imminent death [5] because they can fluctuate owing to factors such as underlying medical conditions and medication use.
The need for clear guidelines for assessing signs and symptoms of imminent death has been highlighted [55]. Specific signs indicative of imminent death within 3 days have been identified in prospective studies of patients with cancer [12, 13, 16, 56]. They include neurocognitive indicators of reduced responsiveness to visual and verbal stimuli and nonreactive pupils; neuromuscular signs, such as drooping of the nasolabial folds, hyperextension of the neck, inability to close the eyelids, and grunting of the vocal cords; and neurological signs, including Cheyne–Stokes breathing, respiration with mandibular movement, and death rattle [12, 13, 16, 56]. The usefulness of these specific signs in caring for patients with neurological diseases warrants examination.
Nurses are expected to contribute to the EOL care decision-making process through their clinical assessments and professional knowledge [17, 57, 58, 59]. However, they may face challenges, including difficulty voicing concerns about ineffective treatments, balancing care needs when families pursue alternative approaches, and managing negative reactions from physicians when advocating for their patients [59]. We aimed to describe nursing contribution to EOL care decision-making and compare the signs and symptoms of imminent death in patients with acute versus progressive neurological diseases during the final 3 to 7 days of life.

Methods

Aim, design, and setting

We aimed to describe nursing contribution to EOL care decision-making and compare the signs and symptoms of imminent death in patients with acute versus progressive neurological diseases during the final 3 to 7 days of life. The study is a single-center, retrospective study of PHRs of documentation of EOL care decision-making, signs and symptoms indicative of impending death, and communication about EOL care with patients admitted to an acute neurological ward and their relatives in the last 3 to 7 days of life.
The study was conducted at Landspitali - University Hospital of Iceland. This hospital has the country’s only specialized acute neurological ward (population around 382,000). All nurses in the neurological ward hold a Bachelor of Science in Nursing (B.S.), and the patient-to-nurse ratio ranges from five to seven patients per nurse. The nurses report to the head nurse of the ward, who is by law accountable for nursing care provision.

Participants

PHRs were included if they fulfilled the following criteria: Healthcare records of patients 18 years or older, admitted to the neurological ward and having the following ICD-10 codes: I60-I64 (stroke diagnoses), G12.2 (ALS), and G20 (Parkinson’s disease) or G25 (extrapyramidal and movement disorders). PHRs of patients with other diagnoses and those of patients with brief hospital stays or minimal documentation in their health records were excluded.

Data collection

Data were collected from 271 PHRs from January 1, 2011 to August 31, 2020. The final analysis included 209 PHRs. Nurses and physicians documented signs and symptoms of impending death. Additionally, data about pain and the nurses’ role in EOL care decision-making were collected from January 1, 2017 to August 31, 2020. The inter-rater reliability of the data collection was acceptable [60].

Instrument

The authors had previously developed a data collection tool, the Neurological End-Of-Life Care Assessment Tool, to extract data from PHRs, including (a) healthcare professionals’ contribution to EOL care (6 items) with identification of patients’ health status as progressing (documented as a worsening or deteriorating condition of the patient) and/or needing EOL care (documented as the need for a treatment directive of EOL care), (b) documentation of EOL care decision-making written by the responsible physician (1 item), (c) signs and symptoms that may inform impending death (22 items), and (d) communication with relatives (3 items) [59]. All items in the Neurological-End-Of-Life Assessment Tool have a nominal value. Additionally, we obtained data about nurses’ contribution to EOL care decision-making from January 1, 2017 to August 31, 2020, using the following three items identified in the RNAO guidelines [17] and relevant literature [21, 23]: information broker, advocate, and supporter. Information broker refers to nurses providing clear, timely information to help patients and families understand treatment options and decisions. Supporter denotes nurses offering emotional and practical support to help patients and families cope with end-of-life challenges, and advocate connotes nurses ensuring that patients’ wishes are respected and upheld in the decision-making process [23]. Each of the three items is reflected in three statements, totaling nine statements, which all have nominal value.

Statistical analysis

All statistical analyses were conducted using the IBM Statistical Package for Social Sciences for Windows (Version 29.0; IBM Corp., Armonk, N.Y., USA). We used descriptive statistical methods to summarize categorical variables, presenting them as frequencies and percentages, and used inferential statistical methods to compare groups. We used the t-test to identify differences in the frequency of signs and symptoms. The chi-square test was used to determine differences in the frequencies of imminent death signs and symptoms between patients receiving and not receiving EOL care, as well as between patients with acute and progressive neurological diseases. Statistical significance was set at p < 0.05. To provide an in depth understanding of nurses’ decision-making beyond the statistical results, excerpts from the PHRs were extracted to illustrate how nurses document patients’ need to transition to EOL care.

Ethics approval

This study was conducted in accordance with the declaration of Helsinki. The study obtained approval from the Ethics Committee at Landspitali, University Hospital of Iceland (reference number 26/2017) for extracting data from PHRs from January 1, 2011 to August 31, 2020. It was reported to the Icelandic Data Protection Authority. A renewal was granted in July 2023 (Nr. 36/2023). This study uses coded data extracted from PHRs, hence no direct patient contact or patient identifiable patient data. Therefore, informed consent was waived by the Ethics committee at Landspitali University Hospital of Iceland and deemed unnecessary according to National Regulations.

Results

Recognition of impending death

Progression of the patient’s disease was recognized in a total of 96% of cases, with nurses and physicians documenting deterioration in 44% and 79% of cases, respectively. Documentation was complete (100%) across all patient groups, except for patients with ischemic stroke, where it was 90% (Table 1). The need for EOL care was documented in 85% of cases, with 36% and 76% documentation rates for nurses and physicians, respectively. The highest frequency of documentation of the need for EOL care by nurses was for patients with ALS (48%), while the lowest was for those with PDoed (9%).
Table 1
Disease progression and need for end-of-life care (N = 209)
 
Total (N = 209)
Stroke– ischemic (n = 123)
Stroke– hemorrhagic (n = 48)
ALS* (n = 27)
PDoed** (n = 11)
N (%)
n (%)
n (%)
n (%)
n (%)
Identified progression of disease
196 (94)
111 (90)
48 (100)
27 (100)
11 (100)
 Nurses
92 (44)
52 (42)
22 (46)
16 (59)
2 (18)
 Physicians
165 (79)
93 (76)
43 (90)
21 (78)
8 (73)
Identified need for EOL*** care
178 (85)
97 (79)
40 (83)
23 (85)
8 (73)
 Nurses
75 (36)
45 (37)
16 (33)
13 (48)
1 (9)
 Physicians
158 (76)
90 (73)
41 (85)
19 (70)
8 (73)
*ALS, amyotrophic lateral sclerosis; **PDoed, Parkinson’s disease or extrapyramidal and movement disorders; ***EOL, end of life
Table 2 shows three distinct roles of nursing contribution to EOL care decision-making. The contribution was most frequent in the role of information broker, with the most frequent individual items being signs and symptoms of impending death (19%) and the need for EOL care (13%).
Table 2
Nursing contribution to decision-making on end-of-life care (N = 85)
Categories
Total
 
N (%)
n (%)
Information broker
36 (15)
 
 End-of-life care is needed
 
11 (13)
 Signs and symptoms of impending death
 
17 (19)
 Communicated with relatives about deterioration
 
8 (9)
Advocate
12 (6)
 
 Contacted physician about the need for end-of-life care
 
5 (6)
 Arranged for a family meeting
 
6 (7)
 Identified need for contacting palliative care team
 
1 (1)
Supporter
14 (6)
 
 Suggested end-of-life care
 
6 (7)
 Allowed family time to process information
 
4 (5)
 Informed relatives about deterioration
 
4 (5)
Table 3 shows excerpts (free text) from the PHRs on how nurses argued for EOL care. These statements reflect clinical judgement of critical symptoms such as unconsciousness, irregular pupil reactions, and rapid breathing to signify the severity of the patient’s condition, communication with the patient’s family, prompt notification of a spouse about the deteriorating condition, and recognition of urgent family’s needs, as well as facilitation of expedient medical care.
Table 3
Excerpts showing argumentation for the need for transition to end-of-life care
Patient with stroke
“During handover, the patient was unconscious and unresponsive to verbal and painful stimuli. The right pupil was fixed and dilated, and the left was near pinpoint. Neither pupil reacted to light. Breathing was rapid but steady. An acute CT** scan revealed a large infarction in the right hemisphere with herniation, indicating imminent death. The patient’s wife was called and informed of the critical situation and was advised to come as quickly as possible.”
Patient with stroke
“The patient seems to be close to dying, but the family is struggling to accept how advanced the disease is. It would be helpful if the physician talks with them again tomorrow and considers adding midazolam PRN***, alongside diazepam and morphine. The dyspnea episodes were difficult for the patient last night; it would have been better for her to receive midazolam rather than repeated suctioning. The patients’ (adult) children do not realize the severity of her condition.”
Patient with ALS*
“It was a difficult night after 3 a.m. The patient received intravenous midazolam, morphine, and diazepam. A decision is needed regarding possible transition to end-of-life care and ensuring comfort in the patient’s final days. He has received tube feeding, but it was stopped today. The patient was awake from 12–5 pm and felt awful; he was grimacing and making sounds. At 4.30 p.m. the patient received 10 mg morphine subcutaneously PRN. It was tough for the family to accept that he was dying, especially seeing him in distress. It is important to reevaluate the current care approach, including whether end-of-life treatment would be appropriate so that adequate sedation could be provided to prevent him from being awake in such discomfort. When he wakes up, he is really bad, he gets all worked up, so it takes time for him to relax again.”
Patient with Parkinson’s disease
“A family meeting has been scheduled for 1 p.m. tomorrow where they will probably decide on end-of-life care. The patient is currently only receiving fluids through a feeding tube. A physician has already reported the deterioration in the patient’s condition to the patient’s grandchildren.”
*ALS, amyotrophic lateral sclerosis; **CT, computed tomography; ***PRN, pro re nata

Demographics of patients

Table 4 presents the characteristics of 209 patients diagnosed with ischemic stroke (n = 123), hemorrhagic stroke (n = 48), ALS (n = 27), or PDoed (n = 11). The average age at the time of death was 79 years (standard deviation = 11.3), with 51% of the patients being women and 55% being married or cohabiting.
Table 4
Demographic characteristics of the analyzed patients (N = 209)
 
Total
(N = 209)
Stroke– ischemic (n = 123)
Stroke– hemorrhagic (n = 48)
ALS*
(n = 27)
PDoed**
(n = 11)
n (%)
n (%)
n (%)
n (%)
n (%)
Age at death (years)
     
 30–49
4
2
2
0
0
 50–69
33
12
6
11
4
 70–89
144
84
37
16
7
 90+
28
25
3
0
0
Women
106 (51)
70 (57)
21 (44)
12 (44)
3 (27)
Men
103 (49)
53 (43)
27 (56)
15 (56)
8 (73)
Single/widowed/divorced
86 (45)
59 (54)
17 (40)
9 (35)
1 (9)
Married/cohabiting
104 (55)
51 (46)
26 (60)
15 (65)
10 (91)
Treatment directive for end-of-life care
181 (87)
108 (88)
44 (92)
21 (78)
8 (73)
*ALS, amyotrophic lateral sclerosis; **PDoed, Parkinson’s disease or extrapyramidal and movement disorders

Comparison and frequency of signs and symptoms between patient groups

Overall, 87% (181) of the patients had a documented EOL care decision. Of the 22 signs and symptoms of imminent death, 5 were excluded owing to a documentation frequency less than 10%, leaving 17 signs and symptoms for further analysis. The remaining signs and symptoms were Cheyne–Stokes breathing, decreased urine output, respiratory congestion, decreased response to verbal stimuli, decreased response to visual stimuli, non-reactive pupils, grunting of vocal cords, no food intake, no fluid intake, fatigue, nausea, dyspnea, agitation, pain, unconscious/limited consciousness, communication (not-responsive), and being bedbound.
The mean number of signs and symptoms in the entire study cohort was 6.5 (range: 1 to 14). The difference in the mean number of signs and symptoms between patients with and without EOL care decision was not significant in the ischemic stroke (6.5 vs. 6.7, t = − 0.378, df = 121, p = 0.706), ALS (5.9 vs. 5.8, t = 0.070, df = 25, p = 0.945), and PDoed groups (5.8 vs. 5.3, (t = 0.336, df = 9, p = 0.744); however, a significant difference was noted in the hemorrhagic stroke group, regardless of the assumption of equal variances (7.2 vs. 4.0, t = 2.246, df = 46, p = 0.030).
Figure 1 shows the difference in the frequency of signs and symptoms between those with and without EOL care decision for all patient groups. For patients with stroke (hemorrhagic and ischemic with EOL care decision, the most common signs and symptoms were unconsciousness or limited consciousness (79%), a non-responsive communication status (78%), immobility or being bedbound (75%), pain (70%), and no food intake (54%). Patients with stroke with EOL care decision had lower frequencies of respiratory congestion (57%), decreased urine output (35%), dyspnea (30%), nausea (20%), and fatigue (18%) than those without EOL care decision.
Among patients with ALS or PDoed, those with EOL care decision had higher frequencies of respiratory congestion (59%), unconsciousness or limited consciousness (45%), being bedbound (45%), nausea (28%), and Cheyne–Stokes breathing (21%) than those without EOL care decision, see Fig. 1. However, they had lower frequencies of pain (72%), a non-responsive communication status (69%), dyspnea (52%), agitation (52%), fatigue (41%), decreased urine output (24%), and no food intake (21%) than patients without EOL care decision.
To further analyze group differences of patients who had documented EOL care decision, significant differences were found among the patient groups. Patients with EOL care decision more commonly had no food intake (chi-square = 7.24, df = 1, p = 0.007) and fatigue (chi-square = 8.03, df = 1 p = 0.005) than those without EOL care decision. Among patients with stroke, a non-responsive communication status was significantly more frequent among those with EOL care decision than in those without EOL care decision (78 vs. 52, chi-square = 6.00, df = 1, p = 0.014). While not statistically significant, patients with ALS/PDoed without EOL care decision showed a higher frequency of a non-responsive communication status than those with EOL care decision (100% vs. 69%, chi-square = 3.660 df = 1, p = 0.056). Additionally, non-significant trends emerged, showing higher frequencies of non-reactive pupils (15% vs. 0%, chi-square = 3.156, df = 1 p = 0.076) in patients with stroke with EOL care decision compared to those patients with stroke without EOL care decision. In patients with ALS/PDoed, unconsciousness or limited consciousness was more frequent among those with EOL care decision than in those without EOL care decision (45% vs. 11%, chi-square = 3.356, df = 1, p = 0.067).
Figure 2 shows the distinct pattern that emerged when we grouped patients based on EOL care decision —acute (ischemic and hemorrhagic stroke) versus progressive (ALS and PDoed). The most pronounced differences were noted in a non-responsive communication status (75%, chi-square = 37.13, df = 1, p = 0.001), being bedbound (73%, chi-square = 15.90, df = 1, p = 0001), no food intake (50%, chi-square = 10.74, df = 1, p = 0.001), unconsciousness or limited consciousness (77%, chi-square = 24.04, df = 1, p = 0.001), and non-reactive pupils (13%, chi-square = 5.46, df = 1, p = 0.019), all of which were more common in patients with stroke than in patients with ALS or PDoed. Conversely, dyspnea (58%, chi-square = 10.27, df = 1, p = 0.001) and fatigue (50%, chi-square = 15.68, df = 1, p = 0.001) were more frequently documented in patients with ALS or PDoed than in those with stroke.

Relatives and family meetings

Table 5 shows that the frequency of informal conversations about EOL care decision-making with patients ranged from 4 to 63%, with the most frequent conversations being documented in those patients with ALS. The frequency of informal conversations with the relatives ranged from 73% (Patients with PDoed) to 87% (Patients with ischemic stroke), and formal family meetings were conducted in most cases or in 82% (Patients with PDoed) to 96% (Patients with hemorrhagic stroke) of cases in the final week of life.
Table 5
Conversations of health care professionals with relatives about end-of-life care (n = 209)
 
Total (N = 209)
Stroke– ischemic (n = 123)
Stroke– hemorrhagic (n = 48)
ALS* (n = 27)
PDoed** (n = 11)
N (%)
n (%)
n (%)
n (%)
n (%)
Informal conversation on EOL*** care with patient
29 (14)
9 (7)
2 (4)
17 (63)
1 (9)
Informal conversation on EOL care with relatives
178 (85)
107 (87)
40 (83)
23 (85)
8 (73)
Family meeting
194 (93)
116 (94)
46 (96)
23 (85)
9 (82)
*ALS, amyotrophic lateral sclerosis; **PDoed, Parkinson’s disease or extrapyramidal and movement disorders; ***EOL, end of life

Discussion

In this study, we examined nursing contributions to EOL care decision-making in patients with neurological diseases, recognition of signs and symptoms of impending death, and interactions with patients and relatives. These aspects are inherently linked to the ultimate EOL care decision-making ordered by physicians. The findings demonstrate that nurses played a multifaceted and essential role, which resonates with recommendations in the literature [17, 56, 57]. The majority of the patients had a documented EOL care decision. Essential to EOL care decision-making is recognizing signs and symptoms of impending death. The mean number of signs and symptoms in all groups (ischemic and hemorrhagic stroke, ALS, and PDoed), was 6.5 and ranged from 1 to 14 in the 3–7 days leading up to death, with patients with hemorrhagic stroke having the highest frequency of documented symptoms (7.2). This is consistent with findings from other studies [3, 4, 8, 10, 15, 16]. The existence of multiple signals should alert health professionals to the approaching EOL. In patients with ALS or PDoed, the documentation focused on dyspnea, agitation, and fatigue, reflecting the progressive nature of their conditions. Conversely, documentation of patients with stroke highlighted issues related to lowered consciousness state, being bedbound, and lack of food intake, underscoring neurological impairment and paralysis. Notably, both groups shared significant overlaps in having a non-responsive communication status, pain, and respiratory congestion, illustrating common challenges these patients face.
Hui et al. [16, 54] conducted prospective studies on signs of imminent death, with a predefined protocol for nurses on how to observe and document these signs. In our study, out of 12 of those signs, 7 had acceptable documentation and were used to report signs of imminent death, namely respiratory congestion, Cheyne–Stokes breathing, decreased response to verbal and visual stimuli, grunting of vocal cords, and non-reactive pupils. The remaining five signs—respiration with mandibular movement, pulselessness of the radial artery, inability to close the eyelids, hyperextension of the neck, and drooping of the nasolabial fold—were documented in less than 10% of the cases. A key difference between our retrospective study and others [12, 13, 16] is that we did not predefine specific factors for healthcare professionals to observe in the clinical setting, allowing us to capture the issues that the healthcare professionals considered needing documentation. Such insight is of value to inform this complicated practice, something that is difficult to depict with prospective study designs.
Patients with stroke, especially those with hemorrhagic stroke, had a higher frequency of documented symptoms than those with ALS or PDoed, likely owing to the acute nature of stroke. Stroke symptoms typically appear suddenly and require close surveillance in the acute phase [36, 38], which leads to more detailed clinical documentation. In contrast, ALS and PDoed symptoms progress gradually [8, 15], potentially resulting in less frequent or detailed documentation. Nurses tend to focus on urgent issues, such as changes in consciousness in patients with stroke, while slower changes in ALS or PDoed, such as reduced response to verbal and visual stimuli, receive less emphasis. This may explain the more thorough documentation in patients with stroke. Further exploration of these findings is needed, but enhancing education on signs and symptoms of approaching death and suggesting preliminary criteria for symptom monitoring may be a beneficial first step toward improving documentation [1].
The findings on communication with patients and relatives reveal differences across different disease groups (ischemic and hemorrhagic stroke, ALS, and PDoed), suggesting variations in their involvement in care decisions. Informal conversations with patients were more common for progressive diseases like ALS than for hemorrhagic stroke. Patients with ALS were also more likely to be conscious and communicating during the final days, while communication with patients with hemorrhagic stroke was minimal. A Swedish study using national EOL registry data found that 93% (n = 770) of patients with ALS were still communicating, and 73% (n = 603) had EOL care discussions with healthcare professionals [11], which is considerably higher than that in our study. A lack of communication guidelines with ALS patients has been identified [14]. Improved competencies among health professionals are needed, encouraging early EOL care discussions with patients facing progressive neurological diseases.
The findings of this study indicate that conversations and formal meetings with relatives of patients about the condition of patients were common during the final week of life. Relatives often provide key insights into patients’ values and wishes, enabling healthcare professionals to tailor care to meet individual needs better. When patients are unconscious or unable to make their own decision, the importance of the relatives in the decision-making process increases. Similar to our study, Ozanne et al. [4] reported a 69–89% prevalence of EOL care discussions with family members, highlighting the beneficial effects of such communication. Similarly, Erikson et al. [10] found that the families of 74% (n = 1195) of patients with stroke received informative communication about transitioning to EOL care. At the same time, Eljas Ahlberg et al. [11] reported that 81% (n = 671) of patients with ALS had transitioned to EOL care discussions.
Evidence-based clinical guidelines on EOL care for patients with neurological diseases are emerging (44,45). Although in their early stages of development, differentiating between the needs of patients with acute (44) and progressive (45,53) neurological diseases has started to take shape, which is congruent with the main implications of this study. Early identification of patients with neurological diseases needing EOL care is a priority, concurrent with further development of evidence-based clinical guidelines for such care. The findings of this study may be useful for that purpose. At the same time, it is crucial to explore further the factors that may contribute to delayed recognition of approaching death in acute care settings [1, 3]. This includes assessing whether signs and symptoms of imminent death are mistaken for acute reversible symptoms [1].

Strengths and limitations

Using real-world data from a specialized neurological ward strengthens the relevance of this study’s findings. However, owing to its retrospective nature, existing documentation was used, which may overlook certain care details and affect the results. While reflective of everyday practice, the single-center setting limits the generalizability of the findings to other healthcare environments. This study assessed various signs and symptoms, comparing those documented in patients with and without EOL care decisions and between individuals with acute and chronic neurological diseases. These comparisons should be interpreted cautiously due to variability documentation and the overall low frequency of documentation. Despite these limitations, the study offers valuable insights into EOL care decision-making in neurological settings, and indicates trends in difference between patient groups, which can inform nurses’ training, improve documentation, and enhance interdisciplinary communication, ultimately leading to better patient care.

Conclusions

Nurses made substantial contributions to EOL care decision-making for patients with neurological diseases, for which the majority had a documented decision. The frequency of signs and symptoms of imminent death was similar between those with and without EOL care decision, except for patients with hemorrhagic stroke, who exhibited a higher frequency among those with EOL care decision compared with those without EOL care decision. The symptom burden was notable for patients without EOL care decision, particularly those with progressive diseases. Further exploration of factors contributing to delayed recognition of the need for EOL care decision in acute settings is paramount. This includes assessing whether the signs and symptoms of imminent death are clear to healthcare professionals or are misinterpreted as acute, reversible conditions.

Acknowledgements

Not applicable.

Declarations

Ethics approval

This study was conducted in accordance with the declaration of Helsinki. The study obtained approval from the Ethics Committee at Landspitali, University Hospital of Iceland (reference number 26/2017) for extracting data from patients’ health records from January 1, 2011 to August 31, 2020 and was reported to the Icelandic Data Protection Authority. A renewal was granted in July 2023 (Nr. 36/2023). This study uses coded data extracted from patient health records and hence no direct patient contact nor patient identifiable patient data. Therefore, informed consent was waived by the Ethics committee at Landspitali University Hospital of Iceland and deemed unnecessary according to National Regulations.
Not applicable.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Colquhoun-Flannery E, Goodwin D, Walshe C. How clinicians recognise people who are dying: an integrative review. Int J Nurs Stud. 2024;151:104666.PubMedCrossRef Colquhoun-Flannery E, Goodwin D, Walshe C. How clinicians recognise people who are dying: an integrative review. Int J Nurs Stud. 2024;151:104666.PubMedCrossRef
2.
Zurück zum Zitat Lundin E, Godskesen TE. End-of-life care for people with advanced dementia and pain: a qualitative study in Swedish nursing homes. BMC Nurs. 2021;20:48.PubMedPubMedCentralCrossRef Lundin E, Godskesen TE. End-of-life care for people with advanced dementia and pain: a qualitative study in Swedish nursing homes. BMC Nurs. 2021;20:48.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Gunasekaran B, Scott C, Ducharlet K, Marco D, Mitchell I, Weil J. Recognising and managing dying patients in the acute hospital setting: can we do better? Intern Med J. 2019;49:119–22.PubMedCrossRef Gunasekaran B, Scott C, Ducharlet K, Marco D, Mitchell I, Weil J. Recognising and managing dying patients in the acute hospital setting: can we do better? Intern Med J. 2019;49:119–22.PubMedCrossRef
4.
Zurück zum Zitat Ozanne A, Sawatzky R, Håkanson C, Alvariza A, Fürst CJ, Årestedt K, et al. Symptom relief during last week of life in neurological diseases. Brain Behav. 2019;9:e01348.PubMedPubMedCentralCrossRef Ozanne A, Sawatzky R, Håkanson C, Alvariza A, Fürst CJ, Årestedt K, et al. Symptom relief during last week of life in neurological diseases. Brain Behav. 2019;9:e01348.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Christ SM, Huynh M, Schettle M, Ahmadsei M, Blum D, Hertler C, et al. Prevalence and predictors for 72-h mortality after transfer to acute palliative care unit. Support Care Cancer. 2022;30:6623–31.PubMedPubMedCentralCrossRef Christ SM, Huynh M, Schettle M, Ahmadsei M, Blum D, Hertler C, et al. Prevalence and predictors for 72-h mortality after transfer to acute palliative care unit. Support Care Cancer. 2022;30:6623–31.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Golla H, Fink G, Rolke R, Lorenzl S, Ebke M, Montag T, et al. New structures in neurology: palliative care for neurological patients. Neurol Int Open. 2017;01:E117–26.CrossRef Golla H, Fink G, Rolke R, Lorenzl S, Ebke M, Montag T, et al. New structures in neurology: palliative care for neurological patients. Neurol Int Open. 2017;01:E117–26.CrossRef
7.
Zurück zum Zitat Ushikubo M. Nurses’ perceptions regarding end-of-life care for individuals with non-cancer diseases on non-invasive positive pressure ventilation-dependent: A qualitative and descriptive study. Indian J Palliat Care. 2023;29:175–80.PubMedPubMedCentralCrossRef Ushikubo M. Nurses’ perceptions regarding end-of-life care for individuals with non-cancer diseases on non-invasive positive pressure ventilation-dependent: A qualitative and descriptive study. Indian J Palliat Care. 2023;29:175–80.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Tiirola A, Korhonen T, Surakka T, Lehto JT. End-of-life care of patients with amyotrophic lateral sclerosis and other nonmalignant diseases. Am J Hosp Palliat Care. 2017;34:154–9.PubMedCrossRef Tiirola A, Korhonen T, Surakka T, Lehto JT. End-of-life care of patients with amyotrophic lateral sclerosis and other nonmalignant diseases. Am J Hosp Palliat Care. 2017;34:154–9.PubMedCrossRef
9.
Zurück zum Zitat Steigleder T, Kollmar R, Ostgathe C. Palliative care for stroke patients and their families: barriers for implementation. Front Neurol. 2019;10:164.PubMedPubMedCentralCrossRef Steigleder T, Kollmar R, Ostgathe C. Palliative care for stroke patients and their families: barriers for implementation. Front Neurol. 2019;10:164.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Eriksson H, Milberg A, Hjelm K, Friedrichsen M. End of life care for patients dying of stroke: A comparative registry study of stroke and cancer. PLoS ONE. 2016;11:e0147694.PubMedPubMedCentralCrossRef Eriksson H, Milberg A, Hjelm K, Friedrichsen M. End of life care for patients dying of stroke: A comparative registry study of stroke and cancer. PLoS ONE. 2016;11:e0147694.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Eljas Ahlberg E, Axelsson B. End-of-life care in amyotrophic lateral sclerosis: A comparative registry study. Acta Neurol Scand. 2021;143:481–8.PubMedCrossRef Eljas Ahlberg E, Axelsson B. End-of-life care in amyotrophic lateral sclerosis: A comparative registry study. Acta Neurol Scand. 2021;143:481–8.PubMedCrossRef
12.
Zurück zum Zitat Hosoi T, Ozone S, Hamano J, Maruo K, Maeno T. Prediction models for impending death using physical signs and vital signs in noncancer patients: a prospective longitudinal observational study. Palliat Med Rep. 2021;2:287–95.PubMedPubMedCentralCrossRef Hosoi T, Ozone S, Hamano J, Maruo K, Maeno T. Prediction models for impending death using physical signs and vital signs in noncancer patients: a prospective longitudinal observational study. Palliat Med Rep. 2021;2:287–95.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Mori M, Yamaguchi T, Maeda I, Hatano Y, Yamaguchi T, Imai K, et al. Diagnostic models for impending death in terminally ill cancer patients: A multicenter cohort study. Cancer Med. 2021;10:7988–95.PubMedPubMedCentralCrossRef Mori M, Yamaguchi T, Maeda I, Hatano Y, Yamaguchi T, Imai K, et al. Diagnostic models for impending death in terminally ill cancer patients: A multicenter cohort study. Cancer Med. 2021;10:7988–95.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Genuis SK, Luth W, Campbell S, Bubela T, Johnston WS. Communication about end of life for patients living with amyotrophic lateral sclerosis: a scoping review of the empirical evidence. Front Neurol. 2021;12:683197.PubMedPubMedCentralCrossRef Genuis SK, Luth W, Campbell S, Bubela T, Johnston WS. Communication about end of life for patients living with amyotrophic lateral sclerosis: a scoping review of the empirical evidence. Front Neurol. 2021;12:683197.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Bhansali S, Assaedi E, Yu JRT, Mandava N, Sonneborn C, Hogue O, et al. End of life care of hospitalized patients with Parkinson disease: a retrospective analysis and brief review. Front Aging Neurosci. 2023;15:1265156.PubMedPubMedCentralCrossRef Bhansali S, Assaedi E, Yu JRT, Mandava N, Sonneborn C, Hogue O, et al. End of life care of hospitalized patients with Parkinson disease: a retrospective analysis and brief review. Front Aging Neurosci. 2023;15:1265156.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Hui D, Dos Santos R, Chisholm G, Bansal S, Souza Crovador C, et al. Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer. 2015;121:960–7.PubMedCrossRef Hui D, Dos Santos R, Chisholm G, Bansal S, Souza Crovador C, et al. Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer. 2015;121:960–7.PubMedCrossRef
18.
Zurück zum Zitat Fernando G, Hughes S. Team approaches in palliative care: a review of the literature. Int J Palliat Nurs. 2019;25:444–51.PubMedCrossRef Fernando G, Hughes S. Team approaches in palliative care: a review of the literature. Int J Palliat Nurs. 2019;25:444–51.PubMedCrossRef
19.
Zurück zum Zitat Virdun C, Luckett T, Davidson PM, Lorenz K, Phillips J. Generating key practice points that enable optimal palliative care in acute hospitals: results from the OPAL project’s mid-point meta-inference. Int J Nurs Stud Adv. 2021;3:100035.PubMedPubMedCentralCrossRef Virdun C, Luckett T, Davidson PM, Lorenz K, Phillips J. Generating key practice points that enable optimal palliative care in acute hospitals: results from the OPAL project’s mid-point meta-inference. Int J Nurs Stud Adv. 2021;3:100035.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Herrera-Abián M, Castañeda-Vozmediano R, Antón-Rodríguez C, Palacios-Ceña D, González-Morales LM, Pfang B, et al. The caregiver’s perspective on end-of-life inpatient palliative care: a qualitative study. Ann Med. 2023;55:2260400.PubMedPubMedCentralCrossRef Herrera-Abián M, Castañeda-Vozmediano R, Antón-Rodríguez C, Palacios-Ceña D, González-Morales LM, Pfang B, et al. The caregiver’s perspective on end-of-life inpatient palliative care: a qualitative study. Ann Med. 2023;55:2260400.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Blaževičienė A, Laurs L, Newland JA. Attitudes of registered nurses about the end-of-ife care in multi-profile hospitals: a cross-sectional survey. BMC Palliat Care. 2020;19:131.PubMedPubMedCentralCrossRef Blaževičienė A, Laurs L, Newland JA. Attitudes of registered nurses about the end-of-ife care in multi-profile hospitals: a cross-sectional survey. BMC Palliat Care. 2020;19:131.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Ó, Coimín D, Prizeman G, Korn B, Donnelly S, Hynes G. Dying in acute hospitals: voices of bereaved relatives. BMC Palliat Care. 2019;18:91.CrossRef Ó, Coimín D, Prizeman G, Korn B, Donnelly S, Hynes G. Dying in acute hospitals: voices of bereaved relatives. BMC Palliat Care. 2019;18:91.CrossRef
23.
Zurück zum Zitat Adams JA, Bailey DE, Anderson RA, Docherty SL. Nursing roles and strategies in end-of-life decision making in acute care: a systematic review of the literature. Nurs Res Prac. 2011;2011:527834. Adams JA, Bailey DE, Anderson RA, Docherty SL. Nursing roles and strategies in end-of-life decision making in acute care: a systematic review of the literature. Nurs Res Prac. 2011;2011:527834.
24.
Zurück zum Zitat Jonsdottir G, Haraldsdottir E, Vilhjalmsson R, Sigurdardottir V, Hjaltason H, Klinke ME, et al. Transition to end-of-life care in patients with neurological diseases in an acute hospital ward. BMC Neuro. 2024;24:253.CrossRef Jonsdottir G, Haraldsdottir E, Vilhjalmsson R, Sigurdardottir V, Hjaltason H, Klinke ME, et al. Transition to end-of-life care in patients with neurological diseases in an acute hospital ward. BMC Neuro. 2024;24:253.CrossRef
25.
Zurück zum Zitat Lloyd J, Pinto AM, Nair S, Tarey S. A qualitative study on palliative needs of stroke patients in an Indian tertiary care setting - doctors’ perspective. Indian J Palliat Care. 2019;25:84–91.PubMedPubMedCentral Lloyd J, Pinto AM, Nair S, Tarey S. A qualitative study on palliative needs of stroke patients in an Indian tertiary care setting - doctors’ perspective. Indian J Palliat Care. 2019;25:84–91.PubMedPubMedCentral
26.
Zurück zum Zitat Asplund K, Lundström S, Stegmayr B. End of life after stroke: A nationwide study of 42,502 deaths occurring within a year after stroke. Eur Stroke J. 2018;3:74–81.PubMedCrossRef Asplund K, Lundström S, Stegmayr B. End of life after stroke: A nationwide study of 42,502 deaths occurring within a year after stroke. Eur Stroke J. 2018;3:74–81.PubMedCrossRef
27.
Zurück zum Zitat Highet G, Crawford D, Murray SA, Boyd K. Development and evaluation of the supportive and palliative care indicators tool (SPICT): a mixed-methods study. BMJ Support Palliat Care. 2014;4:285–90.PubMedCrossRef Highet G, Crawford D, Murray SA, Boyd K. Development and evaluation of the supportive and palliative care indicators tool (SPICT): a mixed-methods study. BMJ Support Palliat Care. 2014;4:285–90.PubMedCrossRef
28.
Zurück zum Zitat Kennedy C, Brooks-Young P, Brunton Gray C, Larkin P, Connolly M, Wilde-Larsson B, et al. Diagnosing dying: an integrative literature review. BMJ Support Palliat Care. 2014;4:263–70.PubMedPubMedCentralCrossRef Kennedy C, Brooks-Young P, Brunton Gray C, Larkin P, Connolly M, Wilde-Larsson B, et al. Diagnosing dying: an integrative literature review. BMJ Support Palliat Care. 2014;4:263–70.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat van Esch HJ, Lokker ME, Rietjens J, van Zuylen L, van der Rijt CCD, van der Heide A. Understanding relatives’ experience of death rattle. BMC Psychol. 2020;8:62.PubMedPubMedCentralCrossRef van Esch HJ, Lokker ME, Rietjens J, van Zuylen L, van der Rijt CCD, van der Heide A. Understanding relatives’ experience of death rattle. BMC Psychol. 2020;8:62.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Watts T, Willis D, Noble S, Johnston B. Death rattle: reassuring harbinger of imminent death or a perfect example of inadequacies in evidence-based practice. Curr Opin Support Palliat Care. 2019;13:380–3.PubMedCrossRef Watts T, Willis D, Noble S, Johnston B. Death rattle: reassuring harbinger of imminent death or a perfect example of inadequacies in evidence-based practice. Curr Opin Support Palliat Care. 2019;13:380–3.PubMedCrossRef
32.
Zurück zum Zitat Gillon S, Clifton IJ. Breathlessness in palliative care: a practical guide. Br J Hosp Med (Lond). 2019;80:72–7.PubMedCrossRef Gillon S, Clifton IJ. Breathlessness in palliative care: a practical guide. Br J Hosp Med (Lond). 2019;80:72–7.PubMedCrossRef
33.
Zurück zum Zitat Hálfdánardóttir SÍ, Ólafsdóttir KL, Sigurðardóttir V. Frequency of symptoms and drug treatment among dying patients in the last 24 hours of life at Landspitali - The National university hospital of Iceland and in nursing homes (Icelandic). Laeknabladid. 2017;2017:223–8.CrossRef Hálfdánardóttir SÍ, Ólafsdóttir KL, Sigurðardóttir V. Frequency of symptoms and drug treatment among dying patients in the last 24 hours of life at Landspitali - The National university hospital of Iceland and in nursing homes (Icelandic). Laeknabladid. 2017;2017:223–8.CrossRef
34.
Zurück zum Zitat Helvig E, Thomassen L, Waje-Andreassen U, Naess H. Comparing withdrawal and non-withdrawal of life-sustaining treatment among patients who died from stroke. Vasc Health Risk Manag. 2015;11:507–10.PubMedPubMedCentral Helvig E, Thomassen L, Waje-Andreassen U, Naess H. Comparing withdrawal and non-withdrawal of life-sustaining treatment among patients who died from stroke. Vasc Health Risk Manag. 2015;11:507–10.PubMedPubMedCentral
35.
Zurück zum Zitat Hausammann R, Maslias E, Amiguet M, Jox RJ, Borasio GD, Michel P. Goals of care changes after acute ischaemic stroke: decision frequency and predictors. BMJ Support Palliat Care. 2022;14:bmjspcare–2022. Hausammann R, Maslias E, Amiguet M, Jox RJ, Borasio GD, Michel P. Goals of care changes after acute ischaemic stroke: decision frequency and predictors. BMJ Support Palliat Care. 2022;14:bmjspcare–2022.
36.
Zurück zum Zitat Parry-Jones AR, Paley L, Bray BD, Hoffman AM, James M, Cloud GC, et al. Care-limiting decisions in acute stroke and association with survival: analyses of UK National quality register data. Int J Stroke. 2016;11:321–31.PubMedCrossRef Parry-Jones AR, Paley L, Bray BD, Hoffman AM, James M, Cloud GC, et al. Care-limiting decisions in acute stroke and association with survival: analyses of UK National quality register data. Int J Stroke. 2016;11:321–31.PubMedCrossRef
37.
Zurück zum Zitat Kim S, Lim A, Jang H, Jeon M. Life-sustaining treatment decision in palliative care based on electronic health records analysis. J Clin Nurs. 2023;32:163–73.PubMedCrossRef Kim S, Lim A, Jang H, Jeon M. Life-sustaining treatment decision in palliative care based on electronic health records analysis. J Clin Nurs. 2023;32:163–73.PubMedCrossRef
38.
Zurück zum Zitat Lank RJ, Shafie-Khorassani F, Zhang X, Ortiz C, Kim S, Case E, et al. Advance care planning and transitions to comfort measures after stroke. J Palliat Med. 2021;24:1191–6.PubMedPubMedCentralCrossRef Lank RJ, Shafie-Khorassani F, Zhang X, Ortiz C, Kim S, Case E, et al. Advance care planning and transitions to comfort measures after stroke. J Palliat Med. 2021;24:1191–6.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat McConvey K, Kazazian K, Iansavichene AE, Jenkins ME, Gofton TE. Triggers for referral to specialized palliative care in advanced neurologic and neurosurgical conditions: a systematic review. Neurol Clin Pract. 2022;12:190–202.PubMedPubMedCentralCrossRef McConvey K, Kazazian K, Iansavichene AE, Jenkins ME, Gofton TE. Triggers for referral to specialized palliative care in advanced neurologic and neurosurgical conditions: a systematic review. Neurol Clin Pract. 2022;12:190–202.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Hussain J, Allgar V, Oliver D. Palliative care triggers in progressive neurodegenerative conditions: an evaluation using a multi-centre retrospective case record review and principal component analysis. Palliat Med. 2018;32:716–25.PubMedCrossRef Hussain J, Allgar V, Oliver D. Palliative care triggers in progressive neurodegenerative conditions: an evaluation using a multi-centre retrospective case record review and principal component analysis. Palliat Med. 2018;32:716–25.PubMedCrossRef
41.
Zurück zum Zitat Bublitz SK, Weck C, Egger-Rainer A, Lex K, Paal P, Lorenzl S. Palliative care challenges of patients with progressive bulbar palsy: a retrospective case series of 14 patients. Front Neurol. 2021;12:700103.PubMedPubMedCentralCrossRef Bublitz SK, Weck C, Egger-Rainer A, Lex K, Paal P, Lorenzl S. Palliative care challenges of patients with progressive bulbar palsy: a retrospective case series of 14 patients. Front Neurol. 2021;12:700103.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Akbar U, McQueen RB, Bemski J, Carter J, Goy ER, Kutner J, et al. Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review. J Neurol Neurosurg Psychiatry. 2021;92:629–36.PubMedCrossRef Akbar U, McQueen RB, Bemski J, Carter J, Goy ER, Kutner J, et al. Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review. J Neurol Neurosurg Psychiatry. 2021;92:629–36.PubMedCrossRef
43.
Zurück zum Zitat Dawson B, McConvey K, Gofton TE. When to initiate palliative care in neurology. In: Miyasaki JM, Kluger BM, editors. Neuropalliative care, part I: handbook of clinical neurology. Volume 190, 3rd ed. Amsterdam: Elsevier; 2022. pp. 105–20.CrossRef Dawson B, McConvey K, Gofton TE. When to initiate palliative care in neurology. In: Miyasaki JM, Kluger BM, editors. Neuropalliative care, part I: handbook of clinical neurology. Volume 190, 3rd ed. Amsterdam: Elsevier; 2022. pp. 105–20.CrossRef
44.
Zurück zum Zitat Creutzfeldt CJ, Bu J, Comer A, Enguidanos S, Lutz B, Robinson MT, Zahuranec DB, Holloway RG, American Heart Association Stroke Council. Council on cardiovascular and stroke nursing; and Council on clinical cardiology. Palliative and End-of-Life care in stroke. Stroke: A Scientific Statement From the American Heart Association; 2024. Creutzfeldt CJ, Bu J, Comer A, Enguidanos S, Lutz B, Robinson MT, Zahuranec DB, Holloway RG, American Heart Association Stroke Council. Council on cardiovascular and stroke nursing; and Council on clinical cardiology. Palliative and End-of-Life care in stroke. Stroke: A Scientific Statement From the American Heart Association; 2024.
46.
Zurück zum Zitat Gofton TE, Chum M, Schulz V, Gofton BT, Sarpal A, Watling C. Challenges facing palliative neurology practice: a qualitative analysis. J Neurol Sci. 2018;385:225–31.PubMedCrossRef Gofton TE, Chum M, Schulz V, Gofton BT, Sarpal A, Watling C. Challenges facing palliative neurology practice: a qualitative analysis. J Neurol Sci. 2018;385:225–31.PubMedCrossRef
48.
Zurück zum Zitat Daneau S, Bourbonnais A, Allard É, Asri M, Ummel D, Bolduc E. Intensive palliative care’: a qualitative study of issues related to nurses’ care of people with amyotrophic lateral sclerosis at end-of-life. Palliat Care Soc Pract. 2023;17:26323524231170881.PubMedPubMedCentralCrossRef Daneau S, Bourbonnais A, Allard É, Asri M, Ummel D, Bolduc E. Intensive palliative care’: a qualitative study of issues related to nurses’ care of people with amyotrophic lateral sclerosis at end-of-life. Palliat Care Soc Pract. 2023;17:26323524231170881.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Murray SA, Boyd K, Moine S, Kendall M, Macpherson S, Mitchell G, et al. Using illness trajectories to inform person centred, advance care planning. BMJ. 2024;384:e067896.PubMedCrossRef Murray SA, Boyd K, Moine S, Kendall M, Macpherson S, Mitchell G, et al. Using illness trajectories to inform person centred, advance care planning. BMJ. 2024;384:e067896.PubMedCrossRef
51.
Zurück zum Zitat Afshar K, van Baal K, Wiese B, Schleef T, Stiel S, Müller-Mundt G, et al. Structured implementation of the supportive and palliative care indicators tool in general practice– A prospective interventional study with follow-up. BMC Palliat Care. 2022;21:214.PubMedPubMedCentralCrossRef Afshar K, van Baal K, Wiese B, Schleef T, Stiel S, Müller-Mundt G, et al. Structured implementation of the supportive and palliative care indicators tool in general practice– A prospective interventional study with follow-up. BMC Palliat Care. 2022;21:214.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Ushikubo M. Circumstances and signs of approaching death in patients with amyotrophic lateral sclerosis undergoing noninvasive ventilation in home care settings. J Neurosci Nurs. 2018;50:182–6.PubMedCrossRef Ushikubo M. Circumstances and signs of approaching death in patients with amyotrophic lateral sclerosis undergoing noninvasive ventilation in home care settings. J Neurosci Nurs. 2018;50:182–6.PubMedCrossRef
53.
Zurück zum Zitat Mead GE, Sposato LA, Sampaio Silva G, Yperzeele L, Wu S, Kutlubaev M, et al. A systematic review and synthesis of global stroke guidelines on behalf of the world stroke organization. Int J Stroke. 2023;18:499–531.PubMedPubMedCentralCrossRef Mead GE, Sposato LA, Sampaio Silva G, Yperzeele L, Wu S, Kutlubaev M, et al. A systematic review and synthesis of global stroke guidelines on behalf of the world stroke organization. Int J Stroke. 2023;18:499–531.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Taylor LP, Besbris JM, Graf WD, Rubin MA, Cruz-Flores S, Epstein LG, et al. Clinical guidance in neuropalliative care: an AAN position statement. Neurology. 2022;98:409–16.PubMedCrossRef Taylor LP, Besbris JM, Graf WD, Rubin MA, Cruz-Flores S, Epstein LG, et al. Clinical guidance in neuropalliative care: an AAN position statement. Neurology. 2022;98:409–16.PubMedCrossRef
56.
Zurück zum Zitat Hui D, dos Santos R, Chisholm G, Bansal S, Silva TB, Kilgore K, et al. Clinical signs of impending death in cancer patients. Oncologist. 2014;19:681–7.PubMedPubMedCentralCrossRef Hui D, dos Santos R, Chisholm G, Bansal S, Silva TB, Kilgore K, et al. Clinical signs of impending death in cancer patients. Oncologist. 2014;19:681–7.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Schofield G, Dittborn M, Huxtable R, Brangan E, Selman LE. Real-world ethics in palliative care: A systematic review of the ethical challenges reported by specialist palliative care practitioners in their clinical practice. Palliat Med. 2021;35:315–34.PubMedCrossRef Schofield G, Dittborn M, Huxtable R, Brangan E, Selman LE. Real-world ethics in palliative care: A systematic review of the ethical challenges reported by specialist palliative care practitioners in their clinical practice. Palliat Med. 2021;35:315–34.PubMedCrossRef
58.
Zurück zum Zitat Bakken J, Wallgren GC, Furnes B, Kørner H, Ueland V. Organizational structures influencing timely recognition and acknowledgment of end-of-life in hospitals - a qualitative study of nurses’ and Doctors’ experiences. Eur J Oncol Nurs. 2023;67:102420.PubMedCrossRef Bakken J, Wallgren GC, Furnes B, Kørner H, Ueland V. Organizational structures influencing timely recognition and acknowledgment of end-of-life in hospitals - a qualitative study of nurses’ and Doctors’ experiences. Eur J Oncol Nurs. 2023;67:102420.PubMedCrossRef
59.
Zurück zum Zitat Lee MN, Kwon S-H, Yu S, Park SH, Kwon S, Kim CH et al. Unveiling nurses’ end-of-life care experiences: moral distress and impacts. Nurs Ethics. 2024;9697330241246086. Lee MN, Kwon S-H, Yu S, Park SH, Kwon S, Kim CH et al. Unveiling nurses’ end-of-life care experiences: moral distress and impacts. Nurs Ethics. 2024;9697330241246086.
60.
Zurück zum Zitat Jonsdottir G, Haraldsdottir E, Sigurdardottir V, Thoroddsen A, Vilhjalmsson R, Tryggvadottir GB, et al. Developing and testing inter-rater reliability of a data collection tool for patient health records on end-of-life care of neurological patients in an acute hospital ward. Nurs Open. 2023;10:5500–8.PubMedPubMedCentralCrossRef Jonsdottir G, Haraldsdottir E, Sigurdardottir V, Thoroddsen A, Vilhjalmsson R, Tryggvadottir GB, et al. Developing and testing inter-rater reliability of a data collection tool for patient health records on end-of-life care of neurological patients in an acute hospital ward. Nurs Open. 2023;10:5500–8.PubMedPubMedCentralCrossRef
Metadaten
Titel
Nursing contribution to end-of-life care decision-making in patients with neurological diseases on an acute hospital ward: documentation of signs and symptoms
verfasst von
Gudrun Jonsdottir
Runar Vilhjalmsson
Valgerdur Sigurdardottir
Haukur Hjaltason
Marianne Elisabeth Klinke
Helga Jonsdottir
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
BMC Nursing / Ausgabe 1/2025
Elektronische ISSN: 1472-6955
DOI
https://doi.org/10.1186/s12912-025-02897-1